Altos Institute of Computation wins award at Virtual Cell Challenge
The team developed Cleo Flow Matching Model for superior perturbation prediction. They presented scGeneScope and PerturBench papers at NeurIPS 2025.
See the latest news and media coverage for Altos. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biotechnology company for cellular rejuvenation research
altoslabs.comLast updated
In short: Altos pursued cellular rejuvenation science to reverse aging and disease, securing a $3 billion investment and acquiring Dorian Therapeutics.
The team developed Cleo Flow Matching Model for superior perturbation prediction. They presented scGeneScope and PerturBench papers at NeurIPS 2025.
The San Diego facility is designed to enhance collaboration and support Altos's mission to reverse disease, injury, and disabilities.
His leadership as Lead Independent Director, Nobel laureate status, and mentorship profoundly shaped Altos' mission and scientific progress.
Joan Mannick, M.D., joins Altos Labs to lead medical and product development efforts focused on cellular rejuvenation therapies.
A research rock star exited a Bezos-backed startup to join a nonprofit. Here's why.
Longevity steps centre-stage as billionaires Jeff Bezos and Yuri Milner launch new antiaging venture Altos Labs.
Cyclana Bio lands funding to advance therapeutics for chronic inflammation diseases, starting with endometriosis.
Altos Labs scientist reveals company is testing organ rejuvenation therapy using Yamanaka factors, aiming to improve discarded organs for...
Track Altos and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Altos and other trending companies.